American Pharmaceutical Security Act Legislation by Sen. Schiff Analyzed
Bill Intros-Senate
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-08-14
Bailey Malota
WASHINGTON, Aug. 14 -- The American Pharmaceutical Security Act, originally introduced by Sen. Adam B. Schiff, D-California, on August 6, 2026, has been analyzed by the Congressional Research Service. This legislation aims to bolster the U.S. market for active pharmaceutical ingredients (APIs) and key starting materials, outlining a need for federal oversight to mitigate reliance on foreign suppliers.
The bill mandates the Administrator of the Centers for Medicare & Medicaid Service . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Aug. 14 -- The American Pharmaceutical Security Act, originally introduced by Sen. Adam B. Schiff, D-California, on August 6, 2026, has been analyzed by the Congressional Research Service. This legislation aims to bolster the U.S. market for active pharmaceutical ingredients (APIs) and key starting materials, outlining a need for federal oversight to mitigate reliance on foreign suppliers.
The bill mandates the Administrator of the Centers for Medicare & Medicaid Service . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com